Laboratorios Dermatologicos Darier Overview

  • Year Founded
  • 1982

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Laboratorios Dermatologicos Darier General Information

Description

Manufacturer of dermatological products. The company's products are researched and developed including topical granules; liquids comprising solutions, suspensions, and syrups, enabling the medical sectors to access proper medication for the treatment of baldness, acne, sunblock, dermatitis, and anti aging.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Insurgentes Sur No 3579
  • Torre 3 Piso 8 801-804
  • Mexico City
  • Mexico
Primary Industry
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • Insurgentes Sur No 3579
  • Torre 3 Piso 8 801-804
  • Mexico City
  • Mexico

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Laboratorios Dermatologicos Darier Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Laboratorios Dermatologicos Darier‘s full profile, request access.

Request a free trial

Laboratorios Dermatologicos Darier Patents

Laboratorios Dermatologicos Darier Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2377080-T3 Topical anti-acne preparations containing retinoid (tazarotene or adapalene), antibiotic (clindamycin phosphate) and / or keratolytic (benzoyl peroxide in microsponges) Active 08-Aug-2006
US-20090318371-A1 Topical antiacne preparations containing retinoid (tazarotene or adapalene), antibiotic (clindamycin phosphate) and/or keratolytic (microsponged benzoyl peroxide) Inactive 08-Aug-2006
EP-2049068-A2 Topical antiacne preparations containing retinoid (tazarotene or adapalene), antibiotic (clindamycin phosphate) and/or keratolytic (miscrosponged benzoyl peroxide) Active 08-Aug-2006
EP-2049068-B1 Topical antiacne preparations containing retinoid (tazarotene or adapalene), antibiotic (clindamycin phosphate) and/or keratolytic (miscrosponged benzoyl peroxide) Inactive 08-Aug-2006
EP-1932525-B1 Skin-care preparations containing mupirocin and betamethasone dipropionate Inactive 02-Sep-2005 A61K31/351
To view Laboratorios Dermatologicos Darier’s complete patent history, request access »

Laboratorios Dermatologicos Darier FAQs

  • When was Laboratorios Dermatologicos Darier founded?

    Laboratorios Dermatologicos Darier was founded in 1982.

  • Where is Laboratorios Dermatologicos Darier headquartered?

    Laboratorios Dermatologicos Darier is headquartered in Mexico City, Mexico.

  • What industry is Laboratorios Dermatologicos Darier in?

    Laboratorios Dermatologicos Darier’s primary industry is Drug Discovery.

  • Is Laboratorios Dermatologicos Darier a private or public company?

    Laboratorios Dermatologicos Darier is a Private company.

  • What is Laboratorios Dermatologicos Darier’s current revenue?

    The current revenue for Laboratorios Dermatologicos Darier is .

  • When was Laboratorios Dermatologicos Darier acquired?

    Laboratorios Dermatologicos Darier was acquired on 01-Jan-2010.

  • Who acquired Laboratorios Dermatologicos Darier?

    Laboratorios Dermatologicos Darier was acquired by GSK.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »